Epicardial FSTL1 Reconstitution Regenerates the Adult Mammalian Heart

Ke Wei,Vahid Serpooshan,Cecilia Hurtado,Marta Diez-Cuñado,Mingming Zhao,Sonomi Maruyama,Wenhong Zhu,Giovanni Fajardo,Michela Noseda,Kazuto Nakamura,Xueying Tian,Qiaozhen Liu,Andrew Wang,Yuka Matsuura,Paul Bushway,Wenqing Cai,Alex Savchenko,Morteza Mahmoudi,Michael D. Schneider,Maurice J. B. van den Hoff,Manish J. Butte,Phillip C. Yang,Kenneth Walsh,Bin Zhou,Daniel Bernstein,Mark Mercola,Pilar Ruiz-Lozano
DOI: https://doi.org/10.1038/nature15372
IF: 64.8
2015-01-01
Nature
Abstract:The elucidation of factors that activate the regeneration of the adult mammalian heart is of major scientific and therapeutic importance. Here we found that epicardial cells contain a potent cardiogenic activity identified as follistatin-like 1 (Fstl1). Epicardial Fstl1 declines following myocardial infarction and is replaced by myocardial expression. Myocardial Fstl1 does not promote regeneration, either basally or upon transgenic overexpression. Application of the human Fstl1 protein (FSTL1) via an epicardial patch stimulates cell cycle entry and division of pre-existing cardiomyocytes, improving cardiac function and survival in mouse and swine models of myocardial infarction. The data suggest that the loss of epicardial FSTL1 is a maladaptive response to injury, and that its restoration would be an effective way to reverse myocardial death and remodelling following myocardial infarction in humans.
What problem does this paper attempt to address?